Nicotinell Icemint (Nicotine Polacrilex)

Nicotine polacrilex is a resin‑bound form of nicotine that releases the drug slowly when the lozenge dissolves in the mouth. The released nicotine is absorbed across the buccal lining, activates nicotinic acetylcholine receptors in the brain, and mimics the stimulant effect of smoking, which eases withdrawal and craving.

The specific dosing regimen for Nicotinell Icemint is determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and treatment goals. The prescriber will advise the number of lozenges per day and the duration of therapy.

Safety data for nicotine polacrilex in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nicotinell Icemint.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nicotinell Icemint delivers nicotine via buccal absorption, offering a slower, steadier release compared with nicotine gum, which requires chewing, and nicotine patches, which provide transdermal delivery. The lozenge can be convenient for users who prefer a discreet, oral option and who may experience less oral irritation than gum.

Store the lozenges at ambient temperature below 25 °C, in the original packaging, protected from moisture, heat, and direct sunlight. Keep out of reach of children and do not use if the package is damaged or the lozenges appear discolored.

Place one lozenge in the mouth and allow it to dissolve slowly without chewing or swallowing whole. Avoid eating or drinking for at least 15 minutes after the lozenge has dissolved to ensure optimal nicotine absorption through the buccal mucosa.

Serious adverse reactions, although rare, include cardiovascular events such as chest pain or hypertension, severe allergic reactions (rash, swelling, difficulty breathing), and gastrointestinal ulceration or bleeding. Users should seek immediate medical attention if any of these symptoms occur.

Individuals with known hypersensitivity to nicotine polacrilex or any component of the lozenge should avoid use. It is also contraindicated in patients with recent myocardial infarction, uncontrolled hypertension, or those currently using other nicotine replacement products without medical supervision.